Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Histogen Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 14 | 13 | −1 |
| Shares | 174.8K | 151.6K | −23.2K (−13.3%) |
| Value | $211.1K | $107.8K | −$103.3K (−48.9%) |
New holders (2)
Institutions that held Histogen Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 16,100 | $11.4K | 0.00% |
| Synovus Financial Corp | 10,050 | $7.15K | 0.00% |
Sold out (3)
Institutions that held Histogen Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 26,536 | $32.0K |
| Susquehanna International Group, LLP | 15,487 | $18.7K |
| UBS Group AG | 6,341 | $7.67K |